A cost comparison of different brands of the same generic name for drugs used in day: To-day life

Pallavi Singh; D Hari Prasath; G Jaya Surya; C M R Kajhareshevarmaa; J Kamalesh; K Vivekanandan

doi:10.53730/ijhs.v6nS2.7723

A cost comparison of different brands of the same generic name for drugs used in day

To-day life

https://doi.org/10.53730/ijhs.v6nS2.7723

Authors

Pallavi Singh Assistant Professor, Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai, India
Hari Prasath. D Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai, India
Jaya Surya. G Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai, India
Kajhareshevarmaa. C M R Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai, India
Kamalesh. J Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai, India
Vivekanandan K Professor, Department of Pharmacy Practice, Faculty of Pharmacy, Dr.M.G.R. Educational and Research Institute, Deemed to be University, Maduravoyal, Chennai-6000095

Keywords:

cost-effectiveness analysis, metformin, folic acid, atorvastatin, ondansetron azithromycin

Abstract

Cost-Effectiveness Analysis (CEA) is a method of examining both the etiology and the health consequence of one or more interventions. It compares one intervention to another by calculating the cost of gaining a unit of a health outcome, such as a life year gained or a death avoided. It is calculated by dividing the total cost of the intervention or medicine by the number of outcome units. This study aimed to determine the cost comparison of different brands of the same generic name for drugs used in day-to-day life. To evaluate the price difference in different brands with same generic drug Collecting the Maximum Retail Price (MRP) of five different drugs namely Metformin, Folic acid, Atorvastatin, Ondansetron and Azithromycin. Cost comparing of different types of brands of same generic name. Calculate the cost effectiveness of each drug using Microsoft excel. Conclusion: In our study cost effective analysis of five different generic drugs with each different brand name, we found that folic acid [FOLCI (5.6)] is more cost effective with lowest MRP as compared with the other entire drug involved in this study

Downloads

Download data is not yet available.

References

Edlin R, Round J, Hulme C, McCabe C. Cost‐effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists. British journal of clinical pharmacology. 2010 Sep;70(3):350-5.[1]

Lopert R, Lang DL, Hill SR, Henry DA. Differential pricing of drugs: a role for cost-effectiveness analysis? The Lancet. 2002 Jun 15;359(9323):2105-7.[2]

Etemad LR, Hay JW. Cost-effectiveness analysis of pharmaceutical care in a Medicare drug benefit program. Value in Health. 2003 Jul 1;6(4):425-35.[3]

Verhoef TI, Morris S. Cost‐effectiveness and pricing of antibacterial drugs. Chemical biology & drug design. 2015 Jan;85(1):4-13.[4]

Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug and alcohol dependence. 2004 Jan 7;73(1):41-50.[5]

Murray CJ, Evans DB, Acharya A, Baltussen RM. Development of WHO guidelines on generalized cost‐effectiveness analysis. Health economics. 2000 Apr;9(3):235-51.[6]

Kassirer JP, Angell M. The journal's policy on cost-effectiveness analyses. New England Journal of Medicine. 1994 Sep 8; 331(10):669-70. Journal policy of cost-effective analysis.[7]

George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making. Pharmacoeconomics. 2001 Nov;19(11):1103-9.- decision making.[8]

Hoyle M. Future drug prices and cost-effectiveness analyses. Pharmacoeconomics. 2008 Jul; 26(7):589-602. Future drug price.[9]

Published

23-05-2022

How to Cite

Singh, P., Hari Prasath, D., Jaya Surya, G., Kajhareshevarmaa, C. M. R., Kamalesh, J., & Vivekanandan, K. (2022). A cost comparison of different brands of the same generic name for drugs used in day: To-day life. International Journal of Health Sciences, 6(S2), 10142–10147. https://doi.org/10.53730/ijhs.v6nS2.7723

Download Citation

Issue

Vol. 6 No. S2 (2022)

Section

Peer Review Articles

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.